Legal & General Group
ARIA

Legal & General Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Legal & General Group’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-65,954
Closed -$820K – 3304
2016
Q4 		$820K Buy
65,954
+19,535
+42% +$235K ﹤0.01% 1822
2016
Q3 		$620K Sell
46,419
-1,715
-4% -$17.2K ﹤0.01% 1601
2016
Q2 		$354K Buy
48,134
+8,825
+22% +$66.2K ﹤0.01% 1523
2016
Q1 		$251K Sell
39,309
-993
-2% -$5.57K ﹤0.01% 1649
2015
Q4 		$254K Buy
40,302
+4,444
+12% +$29.2K ﹤0.01% 1648
2015
Q3 		$210K Hold
35,858
– – ﹤0.01% 1674
2015
Q2 		$293K Buy
35,858
+3,977
+12% +$35.2K ﹤0.01% 1546
2015
Q1 		$269K Buy
31,881
+6,341
+25% +$46.9K ﹤0.01% 1551
2014
Q4 		$176K Sell
25,540
-848
-3% -$5.3K ﹤0.01% 1638
2014
Q3 		$149K Buy
+26,388
New +$154K ﹤0.01% 1655

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Legal & General Group's ARIA Position: Q1 2017 in Review

Legal & General Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 65,954 shares — an estimated $820K sold.

Legal & General Group first reported a position in ARIA in Q3 2014 and held it in 10 quarters. The position peaked at $820K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Legal & General Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Legal & General Group sold 65,954 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $820K.
  • Legal & General Group first reported a position in Ariad Pharmaceuticals Inc in Q3 2014 and held it in 10 quarters.
  • Legal & General Group's Ariad Pharmaceuticals Inc position peaked at $820K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Legal & General Group's 13F filing for Q1 2017, filed 12 May 2017.